TMSS Biomolecular Lab

Our Ongoing Research

No	Research Name	Status
01	Somatic Mutation Landscape of Solid Tumors in Bangladeshi Patients: A Multi-Cancer Analysis of 800+ Cases Using Targeted NGS.	Ongoing
02	EGFR Mutation Spectrum in Non-Small Cell Lung Cancer in Bangladesh: Prevalence, Co-mutations, and Therapeutic Implications from a Real-World NGS Cohort.	Ongoing
03	PIK3CA Mutation Frequency and Actionability in Gynaecological Malignancies in South Asia: First Large-Scale NGS Data from Bangladesh.	Ongoing
04	Genomic Profiling of Acute Myeloid Leukaemia Using the oncoReveal Myeloid Panel: A Bangladeshi Single-Centre Experience and Comparison with Global Datasets.	Ongoing
05	Prevalence of Clinically Actionable Mutations in Solid and Haematological Cancers: A Cross-Tumour NGS Study from a Resource-Limited South Asian Setting.	Ongoing
06	Variant Classification Using AMP/ASCO/CAP Guidelines in a Real-World Cancer NGS Laboratory: Concordance with ClinVar and Therapeutic Decisions in 800 Cases.	Ongoing
07	Targeted Therapy Eligibility Based on NGS Profiling in Bangladeshi Cancer Patients: A Gap Analysis Between Actionable Mutations and Drug Accessibility.	Ongoing
08	Co-occurring Somatic Mutations and Pathway-Level Aberrations Across Multiple Cancer Types: Insights from a 47-Gene NGS Panel in a South Asian Population.	Ongoing
09	Implementation of Clinical-Grade NGS Testing for Cancer in Bangladesh: Laboratory Workflow, Quality Metrics, and First-Year Real-World Outcomes.	Ongoing
10	Comparison of Somatic Mutation Frequencies in South Asian vs. Western Cancer Populations: Evidence from Targeted NGS in Bangladeshi Solid and Liquid Tumours.	Ongoing